Merck raises 2024 profit forecast on cancer drug sales
Merck & Co on Thursday raised its annual profit and revenue forecasts on the back… Read More
1 year ago
Keytruda
Keytruda wins approval as combination therapy for kidney cancer
The drug was approved in combination with Pfizer’s Inlyta to treat advanced renal cell carcinoma. Read More
6 years ago
Merck drug Keytruda succeeds in late-stage esophageal cancer trial
Merck & Co’s blockbuster drug Keytruda met the main goal of a late-stage trial testing… Read More
7 years ago